Environmental and genetic associations with aberrant early-life gut microbial maturation in childhood asthma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background: Environmental, genetic, and microbial factors are independently associated with childhood asthma. Objective: We sought to determine the roles of environmental exposures and 17q12-21 locus genotype in the maturation of the early-life microbiome in childhood asthma. Methods: We analyzed fecal 16s rRNA sequencing at age 3 to 6 months and age 1 year to characterize microbial maturation of offspring of participants in the Vitamin D Antenatal Reduction Trial. We determined associations of microbial maturation and environmental exposures in the mediation of asthma risk at age 3 years. We examined 17q12-21 genotype and microbial maturation associations with asthma risk in Vitamin D Antenatal Reduction Trial and the replication cohort Copenhagen Prospective Studies on Childhood Asthma 2010. Results: Accelerated fecal microbial maturation at age 3 to 6 months and delayed maturation at age 1 year were associated with asthma (P < .001). Fecal Bacteroides was reduced at age 3 to 6 months in association with subsequent asthma (P = .006) and among subjects with lower microbial maturation at age 1 year (q = 0.009). Sixty-one percent of the association between breast-feeding and asthma was mediated by microbial maturation at age 3 to 6 months. Microbial maturation and 17q12-21 genotypes exhibited independent, additive effects on childhood asthma risk. Conclusions: The intestinal microbiome and its maturation mediates associations between environmental exposures including breast-feeding and asthma. The intestinal microbiome and 17q12-21 genotype appear to exert additive and independent effects on childhood asthma risk.

OriginalsprogEngelsk
TidsskriftJournal of Allergy and Clinical Immunology
Vol/bind151
Udgave nummer6
Sider (fra-til)1494-1502
Antal sider8
ISSN0091-6749
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This study was supported by the National Heart, Lung, and Blood Institute (NHLBI; grant no. R01 HL091528 to S.T.W and A.A.L.) and National Institutes of Health Office of the Director (grant no. UH3 OD023268 to S.T.W and A.A.L.). Y.-C.C. is supported by the NHLBI (grant nos. T-32 HL007427 and T-32 AI007306). L.S. is supported by the NHLBI (grant no. K08HL148178). B.C. has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 946228 ). R.S.K. is supported by the NHLBI (grant no. K01 HL146980).

Funding Information:
This study was supported by the National Heart, Lung, and Blood Institute (NHLBI; grant no. R01 HL091528 to S.T.W and A.A.L.) and National Institutes of Health Office of the Director (grant no. UH3 OD023268 to S.T.W and A.A.L.). Y.-C.C. is supported by the NHLBI (grant nos. T-32 HL007427 and T-32 AI007306). L.S. is supported by the NHLBI (grant no. K08HL148178). B.C. has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 946228). R.S.K. is supported by the NHLBI (grant no. K01 HL146980).

Publisher Copyright:
© 2023 American Academy of Allergy, Asthma & Immunology

ID: 371203874